Berlin | Previous Speakers

2018 Speakers Announced Soon

Dr. Franjo Grotenhermen, MD

FOUNDER ACM

Read More
x

Dr. Franjo Grotenhermen, MD

Born in 1957, academic studies of medicine at the University of Cologne. He is running a medical practice, mainly devoted to the medical use of cannabis and cannabinoids. Dr. Grotenhermen is Founder and Chairman of the German Association for Cannabis as Medicine (ACM), Founder and Executive Director of the International Association for Cannabinoid Medicines (IACM) (www.cannabis-med.org) and Chairman of the Medical Cannabis Declaration (MCD). He is editor of the IACM Bulletin, which is published biweekly in several languages and is editor of the internet journal CANNABINOIDS, published on the website of the IACM. He is a Principal of the Nova Institute based near Cologne and author of many articles, books and chapters on the therapeutic potential, pharmacology and toxicology of the cannabinoids.

Jürgen Bickel

MANAGING PARTNER STORZ & BICKEL

Read More
x

Jürgen Bickel

Jürgen Bickel is one of two managing partners at STORZ & BICKEL GmbH & Co. KG, the manufacturer of the first and--to date--only medical cannabinoid vaporizers on the market.

He holds a degree in civil engineering and acted as an international development worker in Peru for five years in the late 1990s, where he was dedicated to the water and sanitation sector in different cities like Chiclayo, Ayacucho and Tumbes.

In 2002, Jürgen Bickel joined Markus Storz, inventor of the VOLCANO Vaporization System as a partner and STORZ & BICKEL GmbH & Co. KG was founded. Together, they established a fast growing and international business with highly demanded products. In 2016, STORZ & BICKEL built its ``S&B Vapor Factory`` in Tuttlingen, Germany, a town with a reputation for being the nexus of medical technology with nearly five hundred medical device manufacturers located there. With the VOLCANO MEDIC and the MIGHTY MEDIC, STORZ & BICKEL provided the only validated application method for the administration of cannabinoids, which was crucial for the overall acceptance of cannabis as medicine.

Linn Baumgardt

DIRECTOR OF MARKETING AT LEAFLY

Read More
x

Linn Baumgardt

As Leafly's Director of Marketing, Linn Baumgardt continuously strives to elevate the cannabis industry by breaking through barriers and parterning with mainstream companies such as Pandora and Twitter. Linn's creativity, strategic mindset and drive to push boundaries have been invaluable in establishing Leafly as the fastest growing privately held company in the Pacific Northwest of the United States. By analyzing market trends and legislation around the world she created a custom algorithm that has become the standard for how Leafly approaches new regions and global markets.

In addition, Linn launched Leafly's largest media campaign, Leafly Vote, in support of cannabis legalization in nine states. Prior to Leafly, Linn worked with companies such as Microsoft, Discovery Channel, and consulted for clients such as Amazon, Sprint, and Red Box.

Dr. Pierre Debs, PhD

CO-FOUNDER MedCann GmbH

Read More
x

Dr. Pierre Debs, PhD

A scientist with 25+ years of academic research experience with genetic engineering, stem cell biology, somatic cell reprogramming and the endocannabinoid system. After a family member with cancer began successfully self-medicating with cannabis extracts, Pierre started searching scientific literature for clues as to why full spectrum cannabis extracts were helping, and found very little. At the same time, he started studying the endocannabinoid system in cancer cells culture, then in various stem cells. In 2015 he left the lab and co-founded MedCann GmbH with the goal to produce cannabis medicines giving German patients more choices, to drive medical cannabis awareness and support clinical research. By the end of July 2016, MedCann had successfully imported medical cannabis from Canada and started distribution to German pharmacies. Going from biological research direct to CEO of a cannabis start-up is an interesting adventure, more so in Germany. By the end of 2016, MedCann was acquired by Canopy Growth Corporation underscoring the importance of Germany to the growing European cannabis industry.

VIEW UPDATES